Lu177 PSMA- Isotopia starts producing Lu177 PSMA for advanced prostate cancer treatment!
February 2016- Isotopia starts producing Lu177 PSMA for advanced prostate cancer treatment and working with collaboration with RAMBAM medical center, the first to use this treatment.
Lutetium-177 PSMA Therapy, or Prostate-Specific Membrane Antigen Therapy, is treatment that is increasingly being used for people with advanced prostate cancer. Lu177 PSMA therapy aims to reduce the size of the tumor and stop them from multiplying, also to ease the symptoms and pain related to bone metastases. It is most often used when the disease has metastasised and when other therapies are poorly tolerated or have failed.